Successful treatment of cerebral vasculitis in an HIV-positive patient with anti-CD25 treatment.
作者信息
Nieuwhof C M G, Damoiseaux J, Tervaert J W Cohen
出版信息
Ann Rheum Dis. 2006 Dec;65(12):1677-8. doi: 10.1136/ard.2005.044867.
Abstract
摘要
相似文献
1
Successful treatment of cerebral vasculitis in an HIV-positive patient with anti-CD25 treatment.
Ann Rheum Dis. 2006 Dec;65(12):1677-8. doi: 10.1136/ard.2005.044867.
2
Spotlight on anti-CD25: daclizumab in MS.
Int MS J. 2008 Sep;15(3):94-8.
3
Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis.
Am J Hematol. 2008 Sep;83(9):747-9. doi: 10.1002/ajh.21236.
4
Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis.
Clin Immunol. 2012 Jan;142(1):9-14. doi: 10.1016/j.clim.2011.10.008. Epub 2011 Nov 9.
5
Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration.
J Autoimmun. 2003 Nov;21(3):283-93. doi: 10.1016/s0896-8411(03)00113-6.
6
Humanized monoclonal anti-CD25 antibody as a novel therapeutic option in HIV-associated psoriatic erythroderma.
J Am Acad Dermatol. 2002 Oct;47(4):635-6. doi: 10.1067/mjd.2002.122751.
7
Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosis.
Arch Neurol. 2009 Apr;66(4):471-9. doi: 10.1001/archneurol.2009.16.
8
Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.
Arch Neurol. 2009 Apr;66(4):483-9. doi: 10.1001/archneurol.2009.50.
9
Humanized anti-CD25 antibody treatment with daclizumab in multiple sclerosis.
Neurodegener Dis. 2008;5(1):23-6. doi: 10.1159/000109934.
10
CD25 saturation rate in heart transplant patients receiving two-dose daclizumab induction.
Transplantation. 2005 Apr 15;79(7):857-8. doi: 10.1097/01.tp.0000152661.43574.6c.
引用本文的文献
1
Diffuse connective tissue disorders in HIV-infected patients.
Mediterr J Rheumatol. 2018 Sep 27;29(3):148-155. doi: 10.31138/mjr.29.3.148. eCollection 2018 Sep.
2
Response of Human Immunodeficiency Virus-Associated Cerebral Angiitis to the Combined Antiretroviral Therapy.
Front Neurol. 2017 Mar 13;8:95. doi: 10.3389/fneur.2017.00095. eCollection 2017.
3
HIV-associated large-vessel vasculopathy: a review of the current and emerging clinicopathological spectrum in vascular surgical practice.
Cardiovasc J Afr. 2015 Mar-Apr;26(2):70-81. doi: 10.5830/CVJA-2015-017.
4
HIV infection and clinical spectrum of associated vasculitides.
Curr Rheumatol Rep. 2011 Dec;13(6):506-12. doi: 10.1007/s11926-011-0214-6.
5
Changes in peripheral CD4+CD25(high) regulatory T cells in the acute-on-chronic liver failure patients with plasma exchange treatment.
Inflammation. 2012 Apr;35(2):436-44. doi: 10.1007/s10753-011-9333-5.
6
T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?
Arthritis Res Ther. 2010;12(1):204. doi: 10.1186/ar2923. Epub 2010 Feb 24.
本文引用的文献
1
A novel therapeutic option in pemphigus vulgaris: humanized monoclonal anti-CD25 antibody.
Br J Dermatol. 2004 Jun;150(6):1220-2. doi: 10.1111/j.1365-2133.2004.05977.x.
2
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta.
Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8705-8. doi: 10.1073/pnas.0402653101. Epub 2004 May 25.
3
Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration.
J Autoimmun. 2003 Nov;21(3):283-93. doi: 10.1016/s0896-8411(03)00113-6.
4
Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsiveness.
Clin Exp Immunol. 2003 Oct;134(1):98-106. doi: 10.1046/j.1365-2249.2003.02256.x.
5
A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitis.
Am J Gastroenterol. 2003 Feb;98(2):369-76. doi: 10.1111/j.1572-0241.2003.07239.x.
6
Cerebral vasculitis after initiation antiretroviral therapy.
AIDS. 2002 Nov 22;16(17):2362-4. doi: 10.1097/00002030-200211220-00028.
7
Alpha-CD25 antibody treatment in a child with hemophagocytic lymphohistiocytosis.
Med Pediatr Oncol. 2002 Feb;38(2):141-2. doi: 10.1002/mpo.1294.
8
9
10
Primary (granulomatous) angiitis of the central nervous system: a clinicopathologic analysis of 15 new cases and a review of the literature.
Hum Pathol. 1992 Feb;23(2):164-71. doi: 10.1016/0046-8177(92)90238-x.
Zotero 插件